» Authors » Alexey V Zakharov

Alexey V Zakharov

Explore the profile of Alexey V Zakharov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 811
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Beasley J, Dorjsuren D, Jain S, Rath M, Tieghi R, Tropsha A, et al.
bioRxiv . 2025 Feb; PMID: 39896648
Antibiotic-resistant bacterial infections loom over humanity as an increasing deadly threat. There exists a dire need for new treatments, especially those that synergize with our existing arsenal of antibiotic drugs...
2.
Martin H, Melo-Filho C, Zakharov A, Muratov E, Tropsha A
Sci Prog . 2025 Jan; 108(1):368504241301535. PMID: 39840476
The recent severe acute respiratory syndrome coronavirus 2 pandemic has clearly exemplified the need for broad-spectrum antiviral (BSA) medications. However, previous outbreaks show that about one year after an outbreak,...
3.
Wellnitz J, Jain S, Hochuli J, Maxfield T, Muratov E, Tropsha A, et al.
J Cheminform . 2025 Jan; 17(1):7. PMID: 39819357
Traditional best practices for quantitative structure activity relationship (QSAR) modeling recommend dataset balancing and balanced accuracy (BA) as the key desired objective of model development. This study explores the value...
4.
Pal S, Nance K, Joshi D, Kales S, Ye L, Hu X, et al.
J Chem Inf Model . 2025 Jan; 65(3):1338-1356. PMID: 39818814
The global impact of SARS-CoV-2 highlights the need for treatments beyond vaccination, given the limited availability of effective medications. While Pfizer introduced , an FDA-approved antiviral targeting the SARS-CoV-2 main...
5.
Doleschal M, Miller J, Jain S, Zakharov A, Rai G, Simeonov A, et al.
ACS Pharmacol Transl Sci . 2024 Sep; 7(9):2827-2839. PMID: 39296272
Ubiquitination is a post-translational modification that elicits a variety of cellular responses. Deubiquitinases (DUBs) remove ubiquitin moieties from proteins and modulate cellular processes by counteracting the ubiquitin ligase activities. Ubiquitination...
6.
Golla K, Yasgar A, Manjuprasanna V, Naik M, Baljinnyam B, Zakharov A, et al.
ACS Pharmacol Transl Sci . 2024 Jul; 7(7):1971-1982. PMID: 39022362
Thrombosis, a key factor in most cardiovascular diseases, is a major contributor to human mortality. Existing antithrombotic agents carry a risk of bleeding. Consequently, there is a keen interest in...
7.
Rath M, Wellnitz J, Martin H, Melo-Filho C, Hochuli J, Silva G, et al.
J Med Chem . 2024 Apr; 67(8):6508-6518. PMID: 38568752
Computational models that predict pharmacokinetic properties are critical to deprioritize drug candidates that emerge as hits in high-throughput screening campaigns. We collected, curated, and integrated a database of compounds tested...
8.
Yu P, Cao S, Yang S, Rai G, Martinez N, Yasgar A, et al.
Cancer Immunol Res . 2023 Dec; 12(2):180-194. PMID: 38051215
Globally, hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers and a leading cause of cancer-related death. We previously identified an immune evasion pathway whereby tumor cells produce...
9.
Alves V, Yasgar A, Wellnitz J, Rai G, Rath M, Braga R, et al.
J Med Chem . 2023 Sep; 66(18):12828-12839. PMID: 37677128
Hits from high-throughput screening (HTS) of chemical libraries are often false positives due to their interference with assay detection technology. In response, we generated the largest publicly available library of...
10.
Dar H, Mikulska-Ruminska K, Tyurina Y, Luci D, Yasgar A, Samovich S, et al.
Proc Natl Acad Sci U S A . 2023 Jun; 120(25):e2218896120. PMID: 37327313
Programmed ferroptotic death eliminates cells in all major organs and tissues with imbalanced redox metabolism due to overwhelming iron-catalyzed lipid peroxidation under insufficient control by thiols (Glutathione (GSH)). Ferroptosis has...